Clincosm LogoSign in Get a demo

leukemia

Showing NaN - NaN of 315
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, MDS, Acute Myeloid Leukemia Trial in Houston (Cladribine)

Not yet recruiting
  • Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 28, 2023

Leukemia Trial in California City, Chicago, Houston (GDX012, Chemotherapy Agents)

Not yet recruiting
  • Leukemia
  • California City, California
  • +2 more
May 24, 2023

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)

Recruiting
  • Leukemia
  • Lymphoma
  • SCRI-CAR22v2
  • Los Angeles, California
  • +4 more
Jan 18, 2023

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022

Leukemia, T-cell Prolymphocytic Leukemia (T-PLL), Cancer Trial in Worldwide (Venetoclax, Ibrutinib)

Completed
Has Results
  • Leukemia
  • +2 more
  • Boston, Massachusetts
  • +14 more
Nov 23, 2022

Leukemia, Lymphoma Trial in Houston (Ofatumumab)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 9, 2022

Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +173 more
Dec 1, 2022

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR

Active, not recruiting
  • Leukemia
  • KIR genotyping
  • HLA genotyping
  • Tampa, Florida
  • +9 more
Nov 29, 2022

Lymphoma, Leukemia Trial in United States (CPI-613)

Recruiting
  • Lymphoma
  • Leukemia
  • Duarte, California
  • +9 more
Nov 28, 2022

Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Leukemia Trial in Boston, Houston (Venetoclax, Standard Chemotherapy)

Recruiting
  • Leukemia
  • Chicago, Illinois
  • +2 more
Oct 3, 2022

Leukemia Trial in Houston (Brentuximab Vedotin, 5-Azacytidine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 7, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

Recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 23, 2022

Acute Lymphoblastic Leukemia, Leukemia Trial in Houston (Ponatinib, Venetoclax, Mini-hyper CVD)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2022

Leukemia Trial in Canada, Puerto Rico, United States (Ruxolitinib, Asparaginase Erwinia Chrysanthemi, Cyclophosphamide)

Recruiting
  • Leukemia
  • Birmingham, Alabama
  • +109 more
Aug 11, 2022

Leukemia, Lymphoblastic, Leukemia Trial in Houston (CB-103, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphoblastic
  • Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Jul 19, 2022

Leukemia, Brain Tumor, Solid Tumor Trial in United States (ALRN-6924, Cytarabine)

Recruiting
  • Leukemia
  • +3 more
  • San Francisco, California
  • +3 more
Jun 14, 2022

Lymphoma, Lymphoma, B-Cell, Leukemia Trial in Houston (Digital Health Coaching)

Recruiting
  • Lymphoma
  • +6 more
  • Digital Health Coaching
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Apr 12, 2022

Leukemia, Myelodysplastic Syndrome(MDS) Trial in Duarte, Houston (fadraciclib)

Recruiting
  • Leukemia
  • Myelodysplastic Syndrome(MDS)
  • Duarte, California
  • +1 more
Apr 1, 2022

CLL, Leukemia Trial in Houston (Eltrombopag)

Completed
  • CLL
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 14, 2022

Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ibrutinib, venetoclax, Placebo)

Active, not recruiting
Has Results
  • Leukemia
  • +2 more
  • Duarte, California
  • +45 more
Jan 27, 2022

Leukemia Trial in Houston (Vosaroxin, Decitabine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 13, 2022